REFERENCES
- Dauer WT, Burke RE, Greene P, Fahn S: Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain 121: 547–560, 1998.
- Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, Krauss JK, Newton A, Rektor I, Savoiardo M, Valls-Solè J: A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 13: 433–444, 2006.
- Jankovic J, Schwartz K: Botulinum toxin injections for cervical dystonia. Neurology 40: 277–280, 1990.
- Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL: Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, doubleblind, placebo controlled study. Mov Disord 20: 783–791, 2005.
- Koller W, Vetere-Overfield B, Gray C, Dubinsky R: Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis. Clin Neuropharmacol 13: 355–358, 1990.
- Dressler D: Electromyographic evaluation of cervical dystonia for planning of botulinum toxin therapy. Eur J Neurol 7: 713–718, 2000.
- Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG: Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve 23: 1752–1756, 2000.
- Brans JW, de Boer IP, Aramideh M, Ongerboer de Visser BW, Speelman JD: Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance. J Neurol 242: 529–534, 1995.
- Walker FO: Botulinum toxin therapy for cervical dystonia. Phys Med Rehabil Clin N Am 14: 749–766, 2003.
- Sung DH, Choi JY, Kim DH, Kim ES, Son YI, Cho YS, Lee SJ, Lee KH, Kim BT: Localization of dystonic muscles with 18F-FDG PET/CT in Idiopathic Cervical Dystonia. J Nucl Med 48: 1790–1795, 2007.
- Cook GJ, Fogelman I, Maisey MN: Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 26: 308–314, 1996.
- Burrell SC, Van den Abbeele AD: 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography of the head and neck: an atlas of normal uptake and variants. Mol Imaging Biol 7: 244–256, 2005.